Showing posts with label VOS viewer. Show all posts
Showing posts with label VOS viewer. Show all posts

Thursday, 27 February 2025

Banking Brilliance Unveiling Trends through Bibliometric and Thematic Lens | Chapter 11 | Leading the Charge: A Guide to Management, Entrepreneurship and Technology in the Dynamic Business Landscape Edition 1

This study aims to conduct a bibliometric and thematic examination of banking efficiency and performance. Using co-citation analysis, scientific mapping, bibliographic coupling, performance evaluation, and bibliographic coupling, the study looks at articles published between 2009 and 2023. The study used thematic clustering, performance analysis, and bibliometric analysis to review 1548 publications from the Scopus database. This study examined several things, including theme mapping, authorship and nation collaborations, the most influential papers, co-occurrence of keywords, co-citations, prolific authors, essential institutions, nations, and the scientific production of publications. The study employed VoS viewer as a tool for performance analysis and thematic clustering. Regarding documents published, 2023 was the most productive year, with 190 articles. The most impactful nations and universities are the United States of America and “Islamic Azad University (Iran)”. The “Journal of Banking and Finance” was the most productive. The authors also identified six research theme clusters about the effectiveness and performance of banks. It gives academics direction and information on the current status of study on the various factors impacting the body of literature on the effectiveness and performance of banks. It also outlines possible directions for further research in this area. For the first time, a thorough performance analysis and scientific mapping of banking efficiency and performance that takes into account all pertinent banking efficiency and performance factors are presented in one study.

 

Author (s) Details

 

Srividhya G.
Amrita School of Business, Amrita Vishwa Vidayapeetham, Bangalore, 560035, India.

 

Thejus V. M.
Amrita School of Business, Amrita Vishwa Vidayapeetham, Bangalore, 560035, India.

 

Vedant Singh
Amrita School of Business, Amrita Vishwa Vidayapeetham, Bangalore, 560035, India.

 

Bhaskar Dhiman
Abhilashi Institute of Technology, Mandi, 175021, India.

 

Please see the book here:- https://doi.org/10.9734/bpi/mono/978-93-48859-98-3/CH11

Thursday, 17 March 2022

A Brief Overview on Global Trends in Immunotherapy Research on Breast Cancer | Chapter 05 | New Horizons in Medicine and Medical Research Vol. 2

 The goal of this work is to utilise bibliometric approaches to assess recent 10-year trends in immunotherapy research in breast cancer, resulting in a better understanding of the present status and trends of those research papers by analysing their primary characteristics. Many research in recent years have focused on the host immune system and its role in tumour growth in a range of solid tumours, including breast cancer. This paper explores contemporary trends in immunotherapy research in breast cancer and compares research contributions from various countries, institutions, and authors. The Web of Science database was searched for breast cancer and immunotherapy research published between 2010 and 2019 using various keyword combinations. For analysis, bibliometric data were gathered. To implement network visualisation study, VOSviewer software was utilised to build a figure for the keyword's co-occurrence network. There were a total of 1,041 publications found. The United States and China generated 336 and 208 publications, respectively, accounting for over half of all publications. Following 2015, both countries spearheaded the increase in publications. The most referenced paper was Nanda et al"Pembrolizumab .'s in Patients with Advanced Triple-Negative Breast Cancer: Phase IB KEYNOTE-012 Study" published in the Journal of Clinical Oncology (715 citations). The keywords discovered in this study were divided into four categories: "mechanism," "vaccination," "PD-L1," and "chemotherapy." The phrases "tumor-infiltrating lymphocytes" and "PD-1/PD-L1" are among the most recent hotspots, appearing largely in 2017. Recent developments in breast cancer immunotherapy have focused on the triple-negative breast cancer subtype and the PD-1/PD-L1 immune checkpoint pathway and inhibitors, according to author keyword analysis. This study examined global trends in breast cancer immunotherapy research over the last decade and gave insight into the features and research hotspots of the articles in this issue.


Author(S) Details


Soo Kyung Ahn
Department of Surgery, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.

Ji Woong Hwang
Department of Surgery, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Seoul, Gwangmyeong, Republic of Korea, South Korea.

View Book:- https://stm.bookpi.org/NHMMR-V2/article/view/6125